Quarterly report pursuant to Section 13 or 15(d)
Cover
Document and Entity Information
Financial Statements
Condensed Consolidated Balance Sheets
Condensed Consolidated Balance Sheets (Parenthetical)
Condensed Consolidated Statements of Operations
Condensed Consolidated Statement of Changes in Stockholders' Equity
Condensed Consolidated Statements of Cash Flows
Notes to Financial Statements
Organization and Description of Business
Summary of Significant Accounting Policies
Collaboration and Stock Purchase Agreements
Inventory
Property and Equipment
Fair Value Measurements
Licenses Acquired
Sponsored Research and Clinical Trial Agreements
Intangibles, net
Debt and Interest
Journey 8% Cumulative Convertible Class A Preferred Offering
Accounts Payable and Accrued Expenses
Non-Controlling Interests
Net Loss per Common Share
Stockholders' Equity
Commitments and Contingencies
Related Party Transactions
Segment Information
Revenues from Contracts and Significant Customers
Income taxes
Subsequent Events
Accounting Policies
Summary of Significant Accounting Policies (Policies)
Notes Tables
Summary of Significant Accounting Policies (Tables)
Inventory (Tables)
Property and Equipment (Tables)
Fair Value Measurements (Tables)
Licenses Acquired (Tables)
Sponsored Research and Clinical Trial Agreements (Tables)
Intangibles, net (Tables)
Debt and Interest (Tables)
Accounts Payable and Accrued Expenses (Tables)
Non-Controlling Interests (Tables)
Net Loss per Common Share (Tables)
Stockholders' Equity (Tables)
Related Party Transactions (Tables)
Segment Information (Tables)
Revenues from Contracts and Significant Customers (Tables)
Notes Details
Organization and Description of Business (Narrative) (Details)
Summary of Significant Accounting Policies (Narrative) (Details)
Summary of Significant Accounting Policies (Schedule of Cash and Cash Equivalents) (Details)
Collaboration and Stock Purchase Agreements (Narrative) (Details)
Inventory (Narrative) (Details)
Inventory (Schedule of Inventory) (Details)
Property and Equipment (Narrative) (Details)
Property and Equipment (Schedule of Property and Equipment) (Details)
Fair Value Measurements (Narrative) (Details)
Fair Value Measurements (Weighted average Significant Unobservable Inputs) (Details)
Fair Value Measurements (Schedule of Financial Instruments, Measured at Fair Value on a Recurring Basis) (Details)
Fair Value Measurements (Roll Forward of the Changes in Fair Value of Level 3 Financial Instruments) (Details)
Licenses Acquired (Narrative) (Details)
Licenses Acquired (Mustang - Narrative) (Details)
Licenses Acquired (Schedule of Research and Development for Licenses Acquired) (Details)
Sponsored Research and Clinical Trial Agreements (Narrative) (Details)
Sponsored Research and Clinical Trial Agreements (Schedule of Research and Development for Sponsored Research and Clinical Trial Agreements) (Details)
Intangibles (Narrative) (Details)
Intangibles (Schedule of Intangible Assets) (Details)
Intangibles (Schedule of JMC Recognized Expense Related to its Product Licenses) (Details)
Intangibles (Schedule of Future Amortization of Intangible Assets) (Details)
Debt and Interest (Narrative) (Details)
Debt and Interest (Schedule of Debt) (Details)
Debt and Interest (Partner company installment payments) (Details)
Debt and Interest (Interest Expense) (Details)
Journey 8% Cumulative Convertible Class A Preferred Offering (Narrative) (Details)
Accounts Payable and Accrued Expenses (Schedule of Accounts Payable and Accrued Liabilities) (Details)
Non-Controlling Interests (Schedule of Non-Controlling Interests in Consolidated Entities) (Details)
Net Loss per Common Share (Schedule of Diluted Weighted Average Shares Outstanding) (Details)
Stockholders' Equity (Narrative) (Details)
Stockholders' Equity (Capital Raises) (Narrative) (Details)
Stockholders' Equity (Stock-Based Compensation Expense) (Details)
Stockholders' Equity (Stock Option Activities) (Details)
Stockholders' Equity (Restricted Stock Awards and Restricted Stock Units) (Details)
Stockholders' Equity (Schedule of Warrant activities) (Details)
Commitments and Contingencies (Narrative) (Details)
Related Party Transactions (Narrative) (Details)
Related Party Transactions (PIK Dividend or Equity Fee Payable) (Details)
Related Party Transactions (Management Services Agreement) (Details)
Segment Information (Narrative) (Details)
Segment Information (Schedule of Segment Information) (Details)
Segment Information (Total assets by reportable segment) (Details)
Revenues from Contracts and Significant Customers (Narrative) (Details)
Revenues from Contracts and Significant Customers (Company's product revenue) (Details)
Income Taxes (Narrative) (Details)
Subsequent Events (Narrative) (Details)
Inventory (Schedule of Inventory) (Details)